PeerVoice Oncology & Haematology Audio-logo

PeerVoice Oncology & Haematology Audio

Education Podcasts >

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
More Information

Location:

United States

Description:

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

Optimising the Treatment of mRCC From the Start: Evaluating the Impact of Evolving First-Line Strategies

6/10/2019
More
Optimising the Treatment of mRCC From the Start: Evaluating the Impact of Evolving First-Line Strategies

Duration:00:16:39

Beyond Positive and Negative HER2 Status: Defining HER2 Levels in Breast Cancer

5/27/2019
More
Beyond Positive and Negative HER2 Status: Defining HER2 Levels in Breast Cancer

Duration:00:19:27

Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy

5/17/2019
More
Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy

Duration:00:28:31

Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions

5/3/2019
More
Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions

Duration:00:25:57

Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer

4/29/2019
More
Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer

Duration:00:29:05

Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression

3/15/2019
More
Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression

Duration:00:21:04

Managing Patients With HER2-Low Breast Cancer

2/19/2019
More
Managing Patients With HER2-Low Breast Cancer

Duration:00:14:26

Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer

2/7/2019
More
Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer

Duration:00:19:40

The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma

1/14/2019
More
The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma

Duration:00:21:50

Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy

11/26/2018
More
Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy

Duration:01:14:44

Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes

9/28/2018
More
Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes

Duration:00:28:07

Best Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma

9/20/2018
More
Best Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma

Duration:00:19:10

Best Practices in Managing CML

8/17/2018
More
Best Practices in Managing CML

Duration:00:17:58

Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer

7/4/2018
More
Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer

Duration:00:19:06

Improving Treatment Monitoring and Therapy Selection in Metastatic Castration-Resistant Prostate Cancer

6/6/2018
More
Improving Treatment Monitoring and Therapy Selection in Metastatic Castration-Resistant Prostate Cancer

Duration:00:16:14

Locally Advanced BCC: Selecting the Right Option to Optimise Outcomes in Your Patients

5/11/2018
More
Locally Advanced BCC: Selecting the Right Option to Optimise Outcomes in Your Patients

Duration:00:18:37

Improving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco

5/9/2018
More
Improving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco

Duration:00:08:24

The Treatment Plan for Patients With Nonmetastatic Prostate Cancer in Canada: Optimizing the Journey From The Beginning

5/3/2018
More
The Treatment Plan for Patients With Nonmetastatic Prostate Cancer in Canada: Optimizing the Journey From The Beginning

Duration:00:26:09

Emerging Biomarkers in Small-Cell Lung Cancer: A New Era

4/30/2018
More
Emerging Biomarkers in Small-Cell Lung Cancer: A New Era

Duration:00:16:43

Improving Outcomes in Later Lines of Therapy for Metastatic Colorectal Cancer

4/11/2018
More
Improving Outcomes in Later Lines of Therapy for Metastatic Colorectal Cancer

Duration:00:18:45